Paraneoplastic Cerebellar Degeneration — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Anti-Hu (ANNA-1) antibody
The best answer is “Anti-Hu (ANNA-1) antibody”. Parkinsonian syndromes are distinguished by tempo, symmetry, eye movements, falls, autonomic and cognitive features; treatment is individualised to motor and neuropsychiatric burden. The alternatives “Anti-NMDA receptor antibody”, “Anti-Yo (PCA-1) antibody”, “Anti-amphiphysin antibody”, “Anti-CASPR2 antibody” are clinically adjacent possibilities, but they do not match the defining chronology, localisation, physiology, investigation result or UK management sequence in this stem.
Reference: NICE NG71 Parkinson disease recommendations: https://www.nice.org.uk/guidance/ng71/chapter/Recommendations